Phase II study of gemcitabine, 5-fluorouracil, and leucovorin in patients with pancreatic cancer

被引：12

作者：

Marantz, A ^{[1
]}

Jovtis, S ^{[1
]}

Almira, E ^{[1
]}

Balbiani, L ^{[1
]}

Castilla, JL ^{[1
]}

Fein, L ^{[1
]}

Lewi, D ^{[1
]}

Pasccon, G ^{[1
]}

Pinckevicius, R ^{[1
]}

Uranga, G ^{[1
]}

Abal, M ^{[1
]}

Muiño, M ^{[1
]}

Reale, M ^{[1
]}

Agusto, S ^{[1
]}

Lastiri, F ^{[1
]}

机构：

[1] Hosp Fernandez, Serv Oncol, Grp Tumores Gastrointestinales, RA-1425 Buenos Aires, DF, Argentina

来源：

SEMINARS IN ONCOLOGY | 2001年 / 28卷 / 03期

关键词：

D O I：

10.1053/sonc.2001.23807

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：44 / 49

页数：6

共 39 条

[1]

Abbruzzese James L., 1994, Cancer Bulletin (Houston), V46, P525

[2]

Ahlgren JD, 1996, SEMIN ONCOL, V23, P241

[3]

BERLIN J, 1997, P AN M AM SOC CLIN, V16, P207

[4]

Bruckner H, 1998, P AM ASSOC CANC RES, V89, P310

[5]

BUKOWSKI RM, 1983, CANCER, V52, P1577, DOI 10.1002/1097-0142(19831101)52:9<1577::AID-CNCR2820520906>3.0.CO

[6]

2-8

[7]

BUKOWSKI RM, 1995, ADV ONCOL, V11, P25

[8] Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial [J].

Burris, HA ;

Moore, MJ ;

Andersen, J ;

Green, MR ;

Rothenberg, ML ;

Madiano, MR ;

Cripps, MC ;

Portenoy, RK ;

Storniolo, AM ;

Tarassoff, P ;

Nelson, R ;

Dorr, FA ;

Stephens, CD ;

VanHoff, DD .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (06) :2403-2413

[9] Phase II study of gemcitabine in patients with advanced pancreatic cancer [J].

Carmichael, J ;

Fink, U ;

Russell, RCG ;

Spittle, MF ;

Harris, AL ;

Spiessi, G ;

Blatter, J .

BRITISH JOURNAL OF CANCER, 1996, 73 (01) :101-105

[10]

CASCINU S, 1998, P AN M AM SOC CLIN, V17, P264

← 1 2 3 4 →